Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival ; day:12 ; month:2 ; year:2022 ; pages:1-13
European journal of nuclear medicine and molecular imaging ; (12.2.2022), 1-13
- Creator
-
Jannin, Arnaud
Lamartina, Livia
Moutarde, Coralie
Djennaoui, Mehdi
Lion, George
Chevalier, Benjamin
Vantyghem, Marie Christine
Deschamps, Frédéric
Hadoux, Julien
Baudin, Eric
Schlumberger, Martin
Leboulleux, Sophie
Cao, Christine Do
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-022-05697-w
- URN
-
urn:nbn:de:101:1-2022051818443700790017
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jannin, Arnaud
- Lamartina, Livia
- Moutarde, Coralie
- Djennaoui, Mehdi
- Lion, George
- Chevalier, Benjamin
- Vantyghem, Marie Christine
- Deschamps, Frédéric
- Hadoux, Julien
- Baudin, Eric
- Schlumberger, Martin
- Leboulleux, Sophie
- Cao, Christine Do
- SpringerLink (Online service)
Other Objects (12)
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Gamma camera-specific reference standards for radioactive iodine uptake measurements
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
Gamma camera-specific reference standards for radioactive iodine uptake measurements
Predictive Factors of Radioactive Iodine Therapy Refractoriness in Patients with Differentiated Thyroid Carcinoma
Causes of False-Positive Radioactive Iodine Uptake in Patients with Differentiated Thyroid Cancer
Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Myxedema Psychosis after Levothyroxine Withdrawal in Radioactive Iodine Treatment of Differentiated Thyroid Cancer: A Case Report
How Radioactive Iodine Treatment Affects the Retina
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
Radioactive Body Burden Measurements in 131 Iodine Therapy for Differentiated Thyroid Cancer: Effect of Recombinant Thyroid Stimulating Hormone in Whole Body 131 Iodine Clearance
68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617
Graves’ Disease-Related Pancytopenia Improved after Radioactive Iodine Ablation
Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence